The Costly Conundrum: Understanding the High Price of Vyzulta in the US

Vyzulta (latanoprostene) is an FDA-approved medication used to treat open-angle glaucoma and ocular hypertension. Both conditions can lead to vision loss, a risk greatly reduced by taking Vyzulta. It is classified as a prostaglandin analog, which increases fluid drainage from the eye, reducing intraocular pressure and safeguarding the optic nerve from damage.

The Cost Disparity:

One of the puzzling aspects of Vyzulta is the difference in pricing between the US and other countries such as Canada. The high cost of Vyzulta as well as many other prescription drugs in the US is caused by a variety of factors. Research and development (R&D) expenses play an important role. Pharmaceutical companies invest substantial resources into discovering and developing new drugs such as Vyzulta. The cost of this, as well as clinical trials and regulatory approvals, play a role in the price of medication.